Liposarcoma, from the CureRays guide library.

Liposarcoma is a cancer that arises from the body's fat cells, most often as a deep, painless mass in a limb or deep in the back of the abdomen; treatment centers on careful surgery, with radiation used to control the microscopic disease that extends beyond the visible tumor and to lower the chance of it coming back.

What it is.

Liposarcoma is a soft-tissue sarcoma — a cancer that begins in connective tissue rather than in an organ lining — that arises from the body's fat cells. It is one of the most common soft-tissue sarcomas in adults. Despite starting in fat, a liposarcoma is not a harmless fatty lump; it is a true cancer that grows, invades nearby tissue, and in its higher-grade forms can spread. Liposarcomas appear in two main settings. In an arm or leg, they show up as a deep, usually painless mass that grows slowly over months. Deep in the back of the abdomen (the retroperitoneum), they can grow very large before causing any symptoms, because there is room there for a tumor to expand quietly until it presses on the kidney, bowel, or other organs. Because these tumors can be mistaken for an ordinary fatty growth (a lipoma), any deep soft-tissue mass that is larger than a few centimeters, growing, or located deep rather than just under the skin should be evaluated by imaging and a biopsy at a sarcoma center rather than simply removed and assumed to be benign. Liposarcoma is really a family of subtypes that behave very differently — some are slow-growing and rarely spread, while others are aggressive and high-grade. Identifying the exact subtype is one of the most important steps, because it determines how the tumor is treated and how closely it must be watched. The cornerstone of treatment is surgery to remove the tumor completely with a margin of healthy tissue; radiation is frequently combined with surgery to treat the microscopic disease that extends beyond the visible mass, and to make a complete, organ- or limb-preserving removal more achievable.

How radiation treats it.

Radiation therapy treats liposarcoma by delivering focused beams of energy that damage the DNA inside tumor cells so they can no longer grow and divide. It is a frequent partner to surgery because of the way these tumors grow: rather than staying neatly within the visible mass, soft-tissue sarcomas push microscopic fingers of tumor into the surrounding fat and connective tissue beyond what can be seen or felt. If only the visible tumor were removed, those microscopic extensions could be left behind and seed a recurrence. Radiation treats a wider zone around the tumor, sterilizing that microscopic disease so the operation can be smaller and more likely to preserve the limb or spare nearby organs, and so the cancer is far less likely to return locally. Radiation can be given before or after surgery. Before surgery, it uses a smaller treatment area and a lower dose, can shrink certain tumors — myxoid liposarcoma is particularly responsive and often shrinks substantially — and can make a complete, function-preserving removal more achievable. After surgery, radiation treats the tumor bed at a higher dose over a larger area when preoperative radiation wasn't given. The choice depends on the tumor's subtype, size, location, and the surgical plan. Subtype matters a great deal: myxoid/round-cell liposarcoma is among the most radiation-sensitive of the sarcomas, so radiation plays a especially valuable role there, while well-differentiated tumors are managed mainly by surgery with radiation reserved for situations where complete removal is difficult. Modern techniques such as intensity-modulated radiation shape the dose tightly around the target, which is especially important in the abdomen, where the kidney, bowel, and other organs sit close to the tumor and limit how much radiation can be given. Radiation also has a role beyond the original site: when liposarcoma spreads to a limited number of spots — the lungs for high-grade types, or the spine and bone for myxoid disease — focused high-dose radiation (stereotactic body radiation) can ablate those deposits and provide durable control without surgery.

The ways we can treat it.

Preoperative (neoadjuvant) radiation. Radiation given before surgery treats the rim of microscopic disease, can shrink certain tumors (myxoid liposarcoma often shrinks markedly), and uses a smaller field and lower dose, making a complete, function-preserving removal more achievable.

Postoperative (adjuvant) radiation. Radiation to the tumor bed after surgery, used when preoperative radiation wasn't given, sterilizes microscopic disease left behind and lowers the chance of local recurrence, at a higher dose over a larger area.

Intensity-modulated radiation (IMRT). Shaping the beams tightly around the target spares surrounding muscle, bowel, kidney, and other organs — particularly important for tumors deep in the abdomen and for preserving limb function.

Stereotactic body radiation (SBRT) for metastases. Focused, high-dose radiation can ablate a limited number of metastases — in the lungs, or in the spine and bone for myxoid disease — providing durable control without surgery.

Questions we hear often.

Is a liposarcoma the same as a fatty lump (lipoma)? No. A lipoma is a common, harmless fatty growth, while a liposarcoma is a true cancer that arises from fat cells and can grow into nearby tissue and, in its higher-grade forms, spread. They can look similar at first, which is exactly why a deep soft-tissue mass that is larger than a few centimeters, growing, or located deep rather than just under the skin should be imaged and biopsied at a sarcoma center rather than simply removed as if it were a lipoma.

Why does the subtype of liposarcoma matter so much? Because liposarcoma is really a family of tumors that behave very differently. A well-differentiated liposarcoma grows slowly and almost never spreads, so it is managed mainly with surgery and follow-up. A myxoid/round-cell tumor is very sensitive to radiation but can spread to unusual sites like the spine and other fatty areas. A pleomorphic or dedifferentiated tumor is high-grade and more likely to spread to the lungs. Knowing the exact subtype — confirmed by expert pathology and molecular testing — tells the team how aggressively to treat, where to look for spread, and how valuable radiation will be.

Will I need radiation if the surgeon removes the whole tumor? Often yes, especially for higher-grade tumors or when a complete margin is hard to achieve. Soft-tissue sarcomas send microscopic fingers of tumor beyond the visible mass, and radiation treats that wider zone so the cancer is less likely to return locally and the operation can be smaller and more tissue- or organ-preserving. For low-grade, well-differentiated tumors that are removed completely, radiation may not be needed and surgery with follow-up may be enough. The decision depends on subtype, grade, size, location, and the surgical margins.

This guide is informational only. It is not medical advice — please confirm anything here with your care team.